Translating Evidence-Based Research into Value-Based Decisions in Oncology

Published Online: Tuesday, November 20, 2012
Follow Pharmacy_Times:
At a meeting hosted by the American Journal of Managed Care, key figures in the managed care industry discussed innovative payment models being utilized by payers and providers.
On Friday, November 16, 2012, the American Journal of Managed Care hosted its first annual live meeting, “Translating Evidence-Based Research into Value-Based Decisions in Oncology.” The meeting, which brought together stakeholders from all sides of the managed care industry, provided an arena for health care professionals to discuss new, innovative payment models being utilized by both payers and providers.
 
To view highlights from the meeting, click here.

Related Articles
Taking more nutritional supplements than needed may increase a patient’s risk of cancer.
The FDA today approved a second-line treatment for metastatic colorectal cancer.
The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.
The FDA has granted Orphan Drug Designation to AstraZeneca’s selumetinib.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$